Dr Juan Antonio Rios Fuentes, MD | |
Carr 2 Km 15.7, Torre Medica Pedro Blanco 1 Suite 313, Manati, PR 00674 | |
(787) 854-7979 | |
(787) 884-3033 |
Full Name | Dr Juan Antonio Rios Fuentes |
---|---|
Gender | Male |
Speciality | Orthopedic Surgery |
Experience | 29 Years |
Location | Carr 2 Km 15.7, Manati, Puerto Rico |
Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
Identifier | Type | State | Issuer |
---|---|---|---|
1922014109 | NPI | - | NPPES |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
207X00000X | Orthopaedic Surgery | 14033 (Puerto Rico) | Primary |
Facility Name | Location | Facility Type |
---|---|---|
Doctors' Center Hospital, Inc | Manati, PR | Hospital |
Mailing Address | Practice Location Address |
---|---|
Dr Juan Antonio Rios Fuentes, MD Pmb 325 Station 425 Carr 693, Dorado, PR 00646 Ph: (787) 854-7979 | Dr Juan Antonio Rios Fuentes, MD Carr 2 Km 15.7, Torre Medica Pedro Blanco 1 Suite 313, Manati, PR 00674 Ph: (787) 854-7979 |
News Archive
UT Southwestern Medical Center neuroscientists have identified key cells within the brain that are critical for determining circadian rhythms, the 24-hour processes that control sleep and wake cycles, as well as other important body functions such as hormone production, metabolism, and blood pressure.
RXi Pharmaceuticals Corporation, a biopharmaceutical company pursuing the development and commercialization of proprietary therapeutics based on RNA interference (RNAi), today announced that Notices of Allowance were recently issued by the United States Patent Office (USPTO) on patent applications filed by Thermo Fisher Scientific Inc. and licensed to RXi Pharmaceuticals encompassing small interfering RNA (siRNA) sequences targeting superoxide dismutase (SOD1), Amyloid beta (A4) precursor protein (APP), interleukin-1 receptor-associated kinase 4 (IRAK4), hepatocyte growth factor receptor (MET protooncogene) and cyclin-dependent kinase (cdk) inhibitor p27 (also known as Kip1, CDKN1B).
Mithridion, Inc., a privately-owned clinical stage drug development company focusing on serious Central Nervous System disorders, announces that the U.S. Food and Drug Administration has awarded Orphan Drug designation for MCD-386CR, its lead drug candidate, for the treatment of Progressive Supranuclear Palsy.
New research from the University of Alabama at Birmingham suggests that Fusobacterium necrophorum more often causes severe sore throats in young adults than streptococcus — the cause of the much better known strep throat.
There are many lawmakers who made their names in health care, seeking to usher through historic changes to a broken system.
› Verified 8 days ago
Yesenia Maria Rodriguez Alvarez, MD Orthopedic Surgery Medicare: Accepting Medicare Assignments Practice Location: Mmc Professional Plaza Suite 407, 200 Calle Hernandez Carrion, Manati, PR 00674 Phone: 612-406-1024 | |
Dr. Onix Reyes-martinez, M.D. Orthopedic Surgery Medicare: Not Enrolled in Medicare Practice Location: Doctor's Center Hospital, Carr #2, Km 47.8, Physical Therapy Canter, Manati, PR 00674 Phone: 787-884-5049 Fax: 787-621-3358 | |
Dr. Jaime F Fumero, Orthopedic Surgery Medicare: Accepting Medicare Assignments Practice Location: Manati Medical Plz, Suit 102, Manati, PR 00674 Phone: 787-921-2050 | |
Dr. Carlos I Carrion Lorenzo, Orthopedic Surgery Medicare: Accepting Medicare Assignments Practice Location: Plaza Puerta Del Sol Num 54, Local 14, Manati, PR 00674 Phone: 787-854-4040 Fax: 787-854-3030 |